Literature DB >> 31472215

Zebrafish as a Model of Neurodevelopmental Disorders.

Murilo S de Abreu1, Rafael Genario2, Ana C V V Giacomini3, Konstantin A Demin4, Anton M Lakstygal5, Tamara G Amstislavskaya6, Barbara Dotto Fontana7, Matthew O Parker7, Allan V Kalueff8.   

Abstract

Neurodevelopmental disorders (NDDs) caused by aberrant brain growth and development are life-long, debilitating illnesses that markedly impair the quality of life. Animal models are a valuable tool for studying NDD pathobiology and therapies. Mounting evidence suggests the zebrafish (Danio rerio) as a useful model organism to study NDDs, possessing both high physiological homology to humans and sensitivity to pharmacological and genetic manipulations. Here, we summarize experimental models of NDDs in zebrafish and highlight the growing translational significance of zebrafish NDD-related phenotypes. We also emphasize the need in further development of zebrafish models of NDDs to improve our understanding of their pathogenesis and therapeutic treatments.
Copyright © 2019 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  animal models; attention-deficit/hyperactivity disorder; autism; genetic models; neurodevelopment

Mesh:

Year:  2019        PMID: 31472215     DOI: 10.1016/j.neuroscience.2019.08.034

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  15 in total

1.  Rrn3 gene knockout affects ethanol-induced locomotion in adult heterozygous zebrafish.

Authors:  Fei Li; Jia Lin; Tingting Li; Jing Jian; Qi Zhang; Yinglan Zhang; Xiuyun Liu; Qiang Li
Journal:  Psychopharmacology (Berl)       Date:  2022-01-10       Impact factor: 4.530

2.  Trehalose Treatment in Zebrafish Model of Lafora Disease.

Authors:  Stefania Della Vecchia; Asahi Ogi; Rosario Licitra; Francesca Abramo; Gabriele Nardi; Serena Mero; Silvia Landi; Roberta Battini; Federico Sicca; Gian Michele Ratto; Filippo Maria Santorelli; Maria Marchese
Journal:  Int J Mol Sci       Date:  2022-06-20       Impact factor: 6.208

3.  Zebrafish behavior as a gateway to nervous system assembly and plasticity.

Authors:  Jessica C Nelson; Michael Granato
Journal:  Development       Date:  2022-05-12       Impact factor: 6.862

Review 4.  Zebrafish as a Model for In-Depth Mechanistic Study for Stroke.

Authors:  Weijie Chen; Lv Xie; Fang Yu; Yan Li; Chen Chen; Wanqing Xie; Tingting Huang; Yueman Zhang; Song Zhang; Peiying Li
Journal:  Transl Stroke Res       Date:  2021-05-29       Impact factor: 6.829

5.  Discovery Sulfoglycomics and Identification of the Characteristic Fragment Ions for High-Sensitivity Precise Mapping of Adult Zebrafish Brain-Specific Glycotopes.

Authors:  Huan-Chuan Tseng; Cheng-Te Hsiao; Nao Yamakawa; Yann Guérardel; Kay-Hooi Khoo
Journal:  Front Mol Biosci       Date:  2021-12-20

Review 6.  Intellectual disability genomics: current state, pitfalls and future challenges.

Authors:  Nuno Maia; Maria João Nabais Sá; Manuel Melo-Pires; Arjan P M de Brouwer; Paula Jorge
Journal:  BMC Genomics       Date:  2021-12-20       Impact factor: 3.969

Review 7.  Understanding autism spectrum disorders with animal models: applications, insights, and perspectives.

Authors:  Zhu Li; Yuan-Xiang Zhu; Li-Jun Gu; Ying Cheng
Journal:  Zool Res       Date:  2021-11-18

8.  Neuropeptide Y: a potential theranostic biomarker for diabetic peripheral neuropathy in patients with type-2 diabetes.

Authors:  Noo Ree Cho; Yeuni Yu; Chang-Kyu Oh; Dai Sik Ko; Kyungjae Myung; Yoonsung Lee; Hee Sam Na; Yun Hak Kim
Journal:  Ther Adv Chronic Dis       Date:  2021-09-08       Impact factor: 5.091

9.  Learning Deficits and Attenuated Adaptive Stress Response After Early-Life Seizures in Zebrafish.

Authors:  Harsimran Singh; Alfonsina Ramon; Dana Finore; Kaleigh Burnham; Scott McRobert; Jocelyn Lippman-Bell
Journal:  Front Neurosci       Date:  2022-04-22       Impact factor: 4.677

Review 10.  Modelling Autism Spectrum Disorder (ASD) and Attention-Deficit/Hyperactivity Disorder (ADHD) Using Mice and Zebrafish.

Authors:  Godfried Dougnon; Hideaki Matsui
Journal:  Int J Mol Sci       Date:  2022-07-07       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.